Plasma albumin, parasitic infection and pubertal development in Egyptian boys

Insights

Parasites and low albumin levels significantly delay puberty onset in Egyptian boys. Lower weight and delayed pubertal development were observed in children with these conditions, highlighting albumin

Area of Science:

  • Pediatric Endocrinology
  • Nutritional Biochemistry
  • Infectious Diseases

Background:

  • Pubertal development is a critical period influenced by nutrition and health.
  • Parasitic infections are prevalent in some regions, potentially impacting child development.
  • Albumin levels reflect nutritional status and overall health.

Purpose of the Study:

  • To investigate the relationship between pubertal staging, albumin concentration, and parasitic infections in Egyptian boys.
  • To determine if nutritional status (albumin) and infection influence the timing of puberty.

Main Methods:

  • Assessed pubertal stage in 453 Egyptian boys (ages 9-17).
  • Measured weight and serum albumin concentrations.
  • Identified parasites in stool samples.

Main Results:

  • Mean age of pubertal development was significantly delayed in boys with low albumin or parasites.
  • The delay was most pronounced in genital stage 2.
  • Lower body weight was associated with reduced albumin or presence of parasites.
  • Positive correlation between weight and albumin in same-aged children (P < 0.001).

Conclusions:

  • Low albumin levels and parasitic infections are associated with delayed puberty in Egyptian boys.
  • Albumin status appears to play a role in the timing of pubertal development.
  • These findings underscore the importance of nutritional status and infection control for healthy adolescent development.

Related Concept Videos

Factors Affecting Protein-Drug Binding: Patient-Related Factors01:29

Factors Affecting Protein-Drug Binding: Patient-Related Factors

Protein-drug binding, a pivotal aspect of pharmacokinetics, is subject to considerable variability influenced by an array of patient-related factors. The intricate interplay of age, individual differences, and pathological conditions significantly impact the binding dynamics and subsequent pharmacological effects.
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Serum Studies: Renal Function Tests01:24

Serum Studies: Renal Function Tests

Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.
Malaria01:29

Malaria

Malaria pathogenesis in humans reflects a delicate interplay between parasite biology and host response. Clinical illness reflects a host’s immune response to the parasite’s asexual replication cycle, which is often asymptomatic in individuals with partial immunity. From the parasite's perspective, transmission between mosquito and human with minimal host pathology is evolutionarily advantageous. Among the six Plasmodium species infecting humans, P. falciparum and P. vivax dominate in global...
Amebiasis01:28

Amebiasis

Entamoeba histolytica, a protozoan parasite, is responsible for intestinal and extraintestinal amebiasis. Though a significant proportion of infections remain asymptomatic, approximately 50 million individuals annually are estimated to present with clinical disease, resulting in up to 100,000 deaths globally. The disease burden is disproportionately high in regions with lower socioeconomic status, such as parts of India, Africa, Mexico, and Latin America.Etiology and TransmissionThe infective...
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...